Description
Book SynopsisThis monograph contains six chapters, each of which provides details about recent advancements in the field of medicine and biology. Chapter One describes the discovery of AZQ, a drug specifically designed to shut off genes that cause brain cancer. Chapter Two analyses the structure, stability, adaptation to extreme environments and the catalytic mechanism of α-helical membrane proteins. Chapter Three provides an up-to-date overview of artificial intelligence (AI) in assisted reproductive treatment (ART) clinics and explores how AI learns and develops a dataset to provide clinical guidance. Chapter Four consists of a study focused on the etiopathogenesis of primary open angle glaucoma using laboratory mice. Chapter Five presents and comments on the current evidence regarding diagnostics in patients with metastatic breast cancer based on circulating tumour cells (CTCs). Lastly, Chapter Six reviews the pathogenetic and clinical features of inner ear involvement in congenital cytomegalovirus (cCMV), the most frequent non-genetic cause of permanent sensorineural hearing loss in childhood.
Table of ContentsPreface; The Impact of Sequencing Human Genome on Genomic Medicine and the Discovery of AZQ (US Patent 4,146,622) Specifically Designed to Shut Off Genes that Cause Brain Cancer; CU(I)-Transport ATPases. Molecular Architecture, Catalysis and Adaptation to Extreme Environments; The AI Doctor Will See You Now: Are Doctors and Embryologists No Longer Indispensable in Assisted Reproductive Treatment (ART)?; Search for New Theories of Etiopathogenesis of Primary Open Angle Glaucoma: Features of Level of Intraocular Pressure and Number of Retinal Ganglion Cells in Conditions of Genetic Defect of Different Subtypes of A1-Adrenoreceptors; Circulating Tumor Cells in Metastatic Breast Cancer: Ready for Clinical Practice?; Inner Ear Involvement in Congenital Cytomegalovirus Infection; Index.
